Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of LY3009104 in Japanese Patients with Active Rheumatoid Arthritis on Background Methotrexate
jRCT2080221667Phase 2
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of baricitinib in rheumatoid arthritis (RA) (5 arms), sponsored by Eli Lilly and Company.
02
Drugs
baricitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT2080221667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221667.